✦ LIBER ✦

Peripartum Clostridium difficile infection: case series and review of the literature

✍ Scribed by Kevin W. Garey; Zhi-Dong Jiang; Yashoo Yadav; Bridget Mullins; Keith Wong; Herbert L. Dupont

Book ID: 113433747
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 141 KB
Volume: 199
Category: Article
ISSN: 1097-6868
DOI: 10.1016/j.ajog.2008.05.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clostridium difficile infection: a revie

Clostridium difficile infection: a review of the literature

✍ Khan, Fahmi Yousef; Elzouki, Abdul-Naser 📂 Article 📅 2014 🏛 Medknow Publications 🌐 English ⚖ 310 KB

Bacteremia due to Clostridium difficile—

Bacteremia due to Clostridium difficile—review of the literature

✍ Donice B. Libby; Gonzalo Bearman 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Acute Appendicitis in the Setting of Clo

Acute Appendicitis in the Setting of Clostridium difficile Colitis: Case Report and Review of the Literature

✍ Brown, Thomas A.; Rajappannair, Lakshmi; Dalton, Arthur B.; Bandi, Ram; Myers, J 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 639 KB

Peripartum cardiomyopathy: A case report

Peripartum cardiomyopathy: A case report and review of the literature

✍ Michael Weinblatt; Marc A. Singer; Imran Iqbal 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 577 KB

Candida prosthetic infections: Case seri

Candida prosthetic infections: Case series and literature review

✍ Dutronc, Herve; Dauchy, Frédéric A.; Cazanave, Charles; Rougie, Catherine; Lafar 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 83 KB

Rifaximin for the treatment of recurrent

Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series

✍ Guy Neff; Victoria Zacharias; Tiffany E. Kaiser; Amy Gaddis; Nyingi Kemmer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 1 views

Previous data have suggested that the nonsystemic antibiotic rifaximin may be effective for the treatment of Clostridium difficile infection (CDI). This single-center retrospective study evaluated the efficacy of rifaximin for the treatment of CDI refractory to standard treatments in patients who ha